Drug-induced pancreatitis

Current Gastroenterology Reports

Volumn 14, Issue 2, 2012, Pages 131-138

  Nitsche, Claudia ^a   Maertin, Sandrina ^a   Scheiber, Jonas ^a   Ritter, Christoph A ^a   Lerch, Markus M ^a   Mayerle, Julia ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Acute pancreatitis; Adverse drug reaction; Aetiology; Drug induced pancreatitis; Medication

Indexed keywords

ALLOPURINOL; ALPHA2B INTERFERON; AZATHIOPRINE; CAPTOPRIL; CLOZAPINE; CODEINE; COLESTYRAMINE; DESOGESTREL; DIDANOSINE; ENALAPRIL; ETHINYLESTRADIOL; FLUINDOSTATIN; FUROSEMIDE; GRISEOFULVIN; LEVONORGESTREL; LITHIUM; MEASLES MUMPS RUBELLA VACCINE; MESALAZINE; OLSALAZINE; OXCARBAZEPINE; PARACETAMOL; PHENYLBUTAZONE; RITONAVIR; SALAZOSULFAPYRIDINE; SIMVASTATIN; STAVUDINE; TICLOPIDINE; UNINDEXED DRUG; VALPROIC ACID; ZALCITABINE;

ABDOMINAL PAIN; ARTICLE; DISEASE CLASSIFICATION; DRUG INDUCED DISEASE; DRUG INDUCED PANCREATITIS; DRUG SURVEILLANCE PROGRAM; HUMAN; INCIDENCE; INFORMATION PROCESSING; PANCREATITIS; POPULATION RESEARCH; PROVOCATION TEST; REFERENCE DATABASE; SYMPTOM; WORLD HEALTH ORGANIZATION;

HUMANS; INCIDENCE; PANCREATITIS; PHARMACEUTICAL PREPARATIONS; RISK FACTORS;

EID: 84861094322     PISSN: 15228037     EISSN: 1534312X     Source Type: Journal    
DOI: 10.1007/s11894-012-0245-9     Document Type: Article

References (44)

1. Lancashire RJ, Cheng K, Langman MJ. Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Aliment Pharmacol Ther. 2003;17:887-93. (Pubitemid 36459601)
2. Andersen V, Sonne J, Andersen M. Spontaneous reports on druginduced pancreatitis in Denmark from 1968 to 1999. Eur J Clin Pharmacol. 2001;57:517-21.
3. Balani AR, Grendell JH. Drug-induced pancreatitis: incidence, managment and prevention. Drug Saf. 2008;31:823-37.
4. Lankisch PG, Droge M, Gottesleben F. Drug induced acute pancreatitis: incidence and severity. Gut. 1995;37:565-7.
5. Vinklerova I, Prochazka M, Prochazka V, Urbanek K. Incidence, severity, and etiology of drug-induced acute pancreatitis. Dig Dis Sci. 2010;55:2977-81.
6. Nitsche CJ, Jamieson N, Lerch MM, Mayerle JV. Drug induced pancreatitis. Best practice & research. Clin Gastroenterol. 2010;24:143-55.
7. Karch FE, Lasagna L. Adverse drug reactions. A critical review. JAMA 1975;234:1236-41.
8. Eland IA, van Puijenbroek EP, Sturkenboom MJ, Wilson JH, Stricker BH. Drug-associated acute pancreatitis: twenty-one years of spontaneous reporting in The Netherlands. Am J Gastroenterol. 1999;94:2417-22. (Pubitemid 29420667)
9. Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol. 2005;39:709-16. (Pubitemid 41177092)
10. Bracamonte JD, Underhill M, Sarmiento P. Acute pancreatitis associated with lisinopril and olanzapine. Am J Health Syst Pharm: AJHP: Official J Am Soc Health Syst Pharm. 2010;67:214-6.
11. Elouni B, Ben Salem C, Zamy M, Sakhri J, Bouraoui K, Biour M. Bortezomib-induced acute pancreatitis. JOP: J Pancreas. 2010;11:275-6.
12. Laczek JT, Shrestha M, Kortan ND, Lake JM. Carbamazepineinduced pancreatitis with positive rechallenge. J Clin Gastroenterol. 2010;44:153-4.
13. Passier JL, van Puijenbroek EP, Jonkers GJ, van Grootheest AC. Pancreatitis associated with the use of itraconazole. Neth J Med. 2010;68:285-9.
14. Sakhri J, Ben Salem C, Harbi H, Fathallah N, Ltaief R. Severe acute pancreatitis due to tamoxifen-induced hypertriglyceridemia with positive rechallenge. JOP: J Pancreas. 2010;11:382-4.
15. Yucel H, Warmerdam LV. Capecitabine-induced pancreatitis. J Oncol Pharm Pract: Official Publication of the International Society of Oncology Pharmacy Practitioners. 2010;16:133-4.
16. Ahmad FA, Mahmud S. Acute pancreatitis following orlistat therapy: report of two cases. JOP: J Pancreas. 2010;11:61-3.
17. Butt W, Saadati H, Saif MW. Oxaliplatin-induced pancreatitis: a case series. Anticancer Res. 2010;30:5113-5.
18. Garg R, Agarwala S, Bhatnagar V. Acute pancreatitis induced by ifosfamide therapy. J Pediatr Surg. 2010;45:2071-3.
19. Garg R, Chen W, Pendergrass M. Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis. Diabetes Care. 2010;33:2349-54.
20. Garg R, Hussey C, Ibrahim S. Pancreatitis associated with the use of sitagliptin and orlistat combination: a case report. Diabet Med: A J Br Diabet Assoc. 2010;27:485-6.
21. Girgis CM, Champion BL. Vildagliptin-induced acute pancreatitis. Endocr Pract: Official J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2011;17:e48-50.
22. Lee PH, Stockton MD, Franks AS. Acute pancreatitis associated with liraglutide. Ann Pharmacother. 2011;45:e22.
23. Pezzilli R, Corinaldesi R, Morselli-Labate AM. Tyrosine kinase inhibitors and acute pancreatitis. JOP: J Pancreas. 2010;11:291-3.
24. Pezzilli R, Fabbri D, Imbrogno A, Corinaldesi R. Tyrosine kinase inhibitors, pancreatic hyperenzymemia and acute pancreatitis: a review. Recent Pat Inflamm Allergy Drug Discov. 2011;5:165-8.
25. Prajapati S, Shah S, Desai C, Desai M, Dikshit RK. Atorvastatininduced pancreatitis. Indian J Pharmacol. 2010;42:324-5.
26. Prot-Labarthe S, Youdaren R, Benkerrou M, Basmaci R, Lorrot M. Pediatric acute pancreatitis related to tigecycline. Pediatr Infect Dis J. 2010;29:890-1.
27. Ruggiero S, DI Nardo R, Polimeno T, Rossi F, Capuano A. Ceftriaxone-induced pancreatitis in a pediatric patient: case report. J Chemother. 2010;22:63-5.
28. Singh V, Devata S, Cheng YC. Carboplatin and docetaxel-induced acute pancreatitis: brief report. Int J Clin Oncol /Jpn Soc Clin Oncol. 2010;15:642-4.
29. Slim R, Ben Salem C, Zamy M, Fathallah N, Raynaud JJ, Bouraoui K, Biour M. Secnidazole-induced acute pancreatitis: a new side-effect for an old drug? JOP: J Pancreas. 2010;11:85-6.
30. Varma MR, Mathew S, Krishnadas D, Vinayakumar KR. Imatinibinduced pancreatitis. Indian J Pharmacol. 2010;42:50-2.
31. Floyd A, Pedersen L, Nielsen GL, Thorlacius-Ussing O, Sorensen HT. Risk of acute pancreatitis in users of azathioprine: a population-based case-control study. Am J Gastroenterol. 2003;98:1305-8. (Pubitemid 36741527)
32. Munk EM, Pedersen L, Floyd A, Norgard B, Rasmussen HH, Sorensen HT. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study. Am J Gastroenterol. 2004;99:884-8. (Pubitemid 39090218)
33. Norgaard M, Ratanajamit C, Jacobsen J, Skriver MV, Pedersen L, Sorensen HT. Metronidazole and risk of acute pancreatitis: a population-based case-control study. Aliment Pharmacol Ther. 2005;21:415-20. (Pubitemid 40313944)
34. Norgaard M, Jacobsen J, Gasse C, Pedersen L, Mortensen PB, Sorensen HT. Selective serotonin reuptake inhibitors and risk of acute pancreatitis: a population-based case-control study. J Clin Psychopharmacol. 2007;27:259-62. (Pubitemid 46763307)
35. Sorensen HT, Jacobsen J, Norgaard M, Pedersen L, Johnsen SP, Baron JA. Newer cyclo-oxygenase-2 selective inhibitors, other non-steroidal anti-inflammatory drugs and the risk of acute pancreatitis. Aliment Pharmacol Ther. 2006;24:111-6. (Pubitemid 43894011)
36. Elmunzer BJ, Waljee AK, Elta GH, Taylor JR, Fehmi SM, Higgins PD. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut 2008;57:1262-7.
37. Floyd A, Pedersen L, Nielsen GL, Thorlacius-Ussing O, Sorensen HT. Risk of acute pancreatitis in users of finasteride: a population-based case-control study. J Clin Gastroenterol. 2004;38:276-8. (Pubitemid 38233338)
38. Tetsche MS, Jacobsen J, Norgaard M, Baron JA, Sorensen HT. Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a population-based case-control study. Am J Gastroenterol. 2007;102:275-8. (Pubitemid 46160540)
39. Thisted H, Jacobsen J, Munk EM, Norgaard B, Friis S, McLaughlin JK, Sorensen HT, Johnsen SP. Statins and the risk of acute pancreatitis: a population-based case-control study. Aliment Pharmacol Ther. 2006;23:185-90. (Pubitemid 43381182)
40. Eland IA, Sundstrom A, Velo GP, Andersen M, Sturkenboom MC, Langman MJ, Stricker BH, Wiholm B. Antihypertensive medication and the risk of acute pancreatitis: the European case-control study on drug-induced acute pancreatitis (EDIP). Scand J Gastroenterol. 2006;41:1484-90. (Pubitemid 44764411)
41. Morinville VD, Lowe ME, Elinoff BD, Whitcomb DC. Hereditary pancreatitis amlodipine trial: a pilot study of a calcium-channel blocker in hereditary pancreatitis. Pancreas. 2007;35:308-12. (Pubitemid 350307372)
42. Anderson SL, Trujillo JM. Association of pancreatitis with glucagon-like peptide-1 agonist use. Ann Pharmacother. 2010;44:904-9.
43. Dore DD, Bloomgren GL, Wenten M, Hoffman C, Clifford CR, Quinn SG, et al. A cohort study of acute pancreatitis in relation to exenatide use. Diabetes Obes Metabol. 2011;13:559-66.
44. Engel SS, Williams-Herman DE, Golm GT, Clay RJ, Machotka SV, Kaufman KD, Goldstein BJ. Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis. Int J Clin Pract. 2010;64:984-90.